Early detection of acute myocardial infarction (AMI) caused by acute, complete, thrombotic coronary occlusion (ACTCO) is a central problem of modern cardiology. The advent of primary percutaneous coronary intervention (PPCI) has transformed the prognosis of patients suffering from this condition. 1 However, PPCI is a time-critical intervention and a delay in diagnosis can be catastrophic for patients. 2 With the exception of posterior AMI and ischaemic left bundle branch block, current international guidelines rely almost exclusively on the single electrocardiographic hallmark of ST elevation (STE) to diagnose ACTCO. 3 Consequently, the description of the electrocardiogram (ECG) phenotype is used synonymously with the condition itself. 4 Under such circumstances, it is easy to fall into the trap of believing that all cases of AMI caused by ACTCO manifest as ST elevation myocardial infarction (STEMI) and that they do so very early in the course of the disease In truth, STE has an excellent documented specificity for AMI but a relatively poor sensitivity, often cited in the range of 40-65%. [5] [6] [7] [8] [9] This figure varies with the anatomical location of the infarct, but the authors would argue that the undifferentiated statistic is the most relevant given the clinical pathway is the same regardless of the ischaemic territory. Furthermore, the assumption that ischaemia caused by ACTCO produces STE more reliably than AMI due to other causes (for example, sub-total coronary occlusion, where noninvasive early management appears to have a much greater role to play [10] [11] [12] ) stems from historic, small-scale studies in animal models. 13, 14 More recent evidence places the sensitivity of STE for early detection of ACTCO in the same range as its sensitivity for AMI in general, as cited above. 15 If this is the case, it is likely Augmenting expert detection of early coronary artery occlusion from 12 lead electrocardiograms using deep learning 
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Early detection of acute myocardial infarction (AMI) caused by acute, complete, thrombotic coronary occlusion (ACTCO) is a central problem of modern cardiology. The advent of primary percutaneous coronary intervention (PPCI) has transformed the prognosis of patients suffering from this condition. 1 However, PPCI is a time-critical intervention and a delay in diagnosis can be catastrophic for patients. 2 With the exception of posterior AMI and ischaemic left bundle branch block, current international guidelines rely almost exclusively on the single electrocardiographic hallmark of ST elevation (STE) to diagnose ACTCO. 3 Consequently, the description of the electrocardiogram (ECG) phenotype is used synonymously with the condition itself. 4 Under such circumstances, it is easy to fall into the trap of believing that all cases of AMI caused by ACTCO manifest as ST elevation myocardial infarction (STEMI) and that they do so very early in the course of the disease In truth, STE has an excellent documented specificity for AMI but a relatively poor sensitivity, often cited in the range of 40-65%. [5] [6] [7] [8] [9] This figure varies with the anatomical location of the infarct, but the authors would argue that the undifferentiated statistic is the most relevant given the clinical pathway is the same regardless of the ischaemic territory. Furthermore, the assumption that ischaemia caused by ACTCO produces STE more reliably than AMI due to other causes (for example, sub-total coronary occlusion, where noninvasive early management appears to have a much greater role to play [10] [11] [12] ) stems from historic, small-scale studies in animal models. 13, 14 More recent evidence places the sensitivity of STE for early detection of ACTCO in the same range as its sensitivity for AMI in general, as cited above. 15 If this is the case, it is likely Augmenting expert detection of early coronary artery occlusion from 12 lead electrocardiograms using deep learning that we are failing to offer one of the most effective interventions in modern medicine to many patients who may benefit from it.
Computerised ECG analysis is widely used to try and improve the quality of ECG interpretation, but sensitivity is consistently lower than expert clinicians. 5, [7] [8] [9] We posit, however, that a deep learning (DL) approach may prove invaluable in this context. In the last decade, exponential increases in computing power coupled with significant advances in machine learning algorithms have provided us with enormously powerful data processing tools. These tools are already discerning new, highly relevant patterns within existing clinical datasets. 16, 17 One could hypothesise that previously unknown patterns also exist within ECG data. For example, a 10 second, 12 lead ECG at 300Hz contains 36000 data points, which is an abundance that cannot be fully exploited by a human clinician. In this study, we aim to explore the possibility that a DL model (a machine learning model based on a neural network architecture with multiple hidden layers: hence, "deep") can provide early detection of ACTCO using 12 lead ECG data. We hypothesise that a DL algorithm will provide a better balance of sensitivity and specificity than either existing STEMI criteria or ECG interpretation by expert cardiologists.
Methods

Data acquisition
ECG signals were downloaded from the STAFF III database (Physionet). [18] [19] [20] This contains a collection of ECGs taken from 104 patients undergoing prolonged intracoronary balloon inflation, which was being studied as an alternative to the series of brief inflations traditionally used during balloon angioplasty at that time . The records consist of the raw signal data from nine lead ECGs stored in a non-proprietary format at 1000Hz (investigators can calculate the three augmented limb leads if they wish). Each patient record contains prolonged ECG recordings upon elective admission to hospital and again during the balloon inflations. The inflations lasted an average of 262 seconds, with 84 lasting in excess of five minutes. The artery undergoing angioplasty varied from patient to patient, but inflations were labelled by artery so this can be accounted for during analysis. For these reasons, STAFF III remains one of the most valuable datasets for groups studying the early ECG effects of prolonged, total coronary occlusion in humans.
Ethical considerations
We did not identify any ethical issues within this study, as we were exclusively using open data from an anonymised, publicly-available database. This decision was ratified by the heads of research governance at two of the participating academic centres (Ulster University and Southern Health and Social Care Trust).
Inclusion / exclusion criteria
We excluded records where lead placement was documented to be incorrect, and we further excluded records where balloon inflations lasted less than 90 seconds. This left us with ECG records from 76 patients. Several of these patients underwent multiple inflations but we only used the data from the first inflation as we did not want "hangover" electrical effects to be a confounding factor. We also discarded the first 60 seconds of each inflation trace on the basis that the electrophysiological effects of myocardial ischaemia would not manifest immediately upon coronary occlusion, and that an accurate diagnosis of ACTCO at the one minute mark would be adequate for any clinical advantage the system may offer.
Algorithm design
For the DL model, we used a 34-layer convolutional neural network (CNN) with residual connections culminating in a fully connected layer with a single, sigmoid-activated output node. Researchers from the Stanford Machine Learning Group have identified this architecture as being particularly well-suited to processing ECG signal data, 21 and our group has previously presented work using similar models for automated detection of atrial fibrillation (AF). 22 We initiated the model for the current study using weights from the AF task, on the basis that many ECG features learned during arrhythmia analysis would transfer across to ischaemia detection.
During the training process, we split ECG signals into one second segments. Each ECG window was reshaped into a 9000 dimensional vector (nine leads x 1000Hz x one second) and fed into the DL model. The loss function was based on a simple binary classification task: 0 for ECG traces where there was no acute coronary occlusion, 1 for traces that were recorded during intracoronary balloon inflation. (Full details of the training process will be included in a separate technical paper.)
Algorithm evaluation
Following the training process, the model was evaluated using a 5 fold cross-validation (CV) process. The test set consisted of a single 10 second ECG trace for each patient at baseline (negative examples), then another 10 second trace for each patient one minute into intracoronary balloon inflation (positive examples, 152 ECGs in total). Each version of the model used during CV was completely naïve to any data from the patients whose ECGs it was tasked with analysing. The model was not programmed with ongoing memory capabilities and was naïve to the class distribution, so each ECG analysis constituted an independent classification task. Binarisation of the predictions was based on the decision threshold that maximised the F1 score, which was fixed across all five CV cycles. The mean results of the five CV cycles were taken as the final outcome of evaluation process. Confidence intervals (95%) were also calculated for each metric.
Reliable benchmarks for the sensitivity and specificity of both STE criteria and clinician interpretation of ECGs regarding the presence of myocardial ischaemia exist in the literature.5,7-9 However, in order to demonstrate that the results obtained from the STAFF III dataset are robust, the same ECGs upon which the DL model was evaluated were plotted into human readable form and given to three consultant cardiologists (SL -25 years clinical experience, DJM -32 years clinical experience, and DEG -38 years clinical experience). Consideration was given to asking a larger number of clinicians to undertake the task, but this study was a proof-of-concept regarding the utility of deep learning for ACTCO detection rather than an attempt to definitively prove its superiority over expert cardiologists (which would, in any case, require a more extensive dataset). Hence, it was concluded that three reviewers whom one would expect to perform well above the average clinician was a suitable number, as it allowed for majority consensus where opinions differed.
The cardiologists were aware of the context of the STAFF III study and were unblinded to the 1:1 class distribution of the traces, as some patients had longterm ECG abnormalities at baseline and we wanted the clinicians to be aware that they were seeking to identify only acute ischaemic changes. The cardiologists were, however, blinded to the labels of the ECGs themselves. They were asked to classify the traces as showing either "ST elevation" (defined as 1mm STE in two contiguous leads or 1.5mm in V2 and V3), "non-specific ischaemic changes" as per their own discretion, or "neither". Augmented limb leads were calculated and added for human reviewers. Where consensus opinion was measured, labels were considered positive or negative based on the majority vote of the three cardiologists.
Statistical analysis
We calculated the accuracy of each classifier by dividing the number of correct labels with the total number of ECGs labelled. We were particularly interested in the statistical significance of the DL model's accuracy against the consensus opinion of the three expert cardiologists, which we took to be the current gold standard regarding the presence of acutely ischaemic ECG changes. This was evaluated using the chi-square test. For each classifier we also calculated the sensitivity, specificity, positive predictive value (PPV) and F1 score (see equation 1 below).
× ( × ) ÷ ( + ) Equation 1 -the F1 score
We split the examples into subgroups based on anatomical location of the balloon inflation. There were five subgroups: left main stem (LMS), left anterior descending artery (LAD), diagonal branches (diag), left circumflex artery (LCx) and right coronary artery (RCA). Each group consisted of all the negative ECG examples plus positive examples for each artery. Given that positive examples were sparse in some subgroups, we evaluated sensitivity, specificity, PPV and accuracy for statistically significant deviation from random chance using the binomial test. We evaluated the classifiers for marginal homogeneity using McNemar's test.
A receiver operating characteristic (ROC) curve was plotted for the DL model and area under the ROC (AUROC) calculated.
Results
Basic demographic information from the STAFF III subjects included within our study are shown in table 1.
The results of ECG analysis by ST-elevation criteria (as defined by consensus opinion among the three reviewing experts), individual analysis by each expert using a combination of both STEMI criteria and nonspecific ischaemic changes, consensus analysis among the experts using both STEMI criteria and non-specific ischaemic changes, and analysis by the DL model are shown in figure 1. The DL model had both the highest accuracy (0.803) and the highest F1 score (0.814). Classification using the STEMI criteria produced the highest specificity (0.947). Cardiologist 3 achieved the highest sensitivity (0.842).
The confusion matrices used to calculate these results are included in appendix 1. As previously noted, the DL model's results were calculated by taking the mean results of each cycle of the 5-fold CV process. Confidence intervals (95%) for these results are shown in figure 2.
We evaluated difference in accuracy between the DL model and the consensus cardiologist opinion using the chi-square test and found it to be significant using a threshold of 0.05 (p=0.0469). We also evaluated marginal homogeneity using McNemar's test. Results are shown in table 2 (see pages [8] [9] . 7 (The clinician's interpretation of the ECGs was used to inform decisions regarding thrombolysis during this study, which was recognised to have rare but significant complications. 23 This likely explains the favouring of specificity over sensitivity.) Menown et al (2000) studied various definitions of STE and their effects on sensitivity and specificity for AMI within a set of ECGs from 603 patients (132 positive examples, 471 negative examples, where AMI was defined by a combination of clinical features, ECG changes and biomarkers). The widely-used model of ≥ 1mm STE in two contiguous leads achieved sensitivity 0.491, specificity 0.932, PPV 0.669, accuracy 0.835 and F1 0.566. 5 Garvey et al (2016) report the results from three modern computerised ECG analysers. Their dataset was based on 118 ECGs from patients with ACTCO identified at primary angiography and 382 ECGs from patients presenting with chest pain but either deemed unsuitable for PPCI or having no ACTCO identified at primary angiography. The mean results and ranges for the automated analysers were: sensitivity 0.663 (0.620-0.690), specificity 0.917 (0.890-0.950), PPV 0.718
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Comparison of binary classifiers is notoriously difficult because the optimal balance between sensitivity and specificity is entirely context dependent. When it comes to early detection of ACTCO, high specificity at the cost of sensitivity could result in "false negative" patients missing out on crucial intervention for a life-threatening condition. High sensitivity at the cost of specificity, conversely, exposes "false positive" patients to unnecessary procedure-related complications and could place unacceptable strain on healthcare resources: hence, STE remains useful. Of note, Ballah et al (2013) report that the cardiologists at their centre expressed a desire for a false activation rate of the PPCI pathway ≤ 10%. 8 To the best of the authors' knowledge, no ECG classifier (human or computerised) meeting this stipulation achieves a sensitivity for ACTCO above 0.68, and we would question whether such a strict threshold is in patients' best interests. Ultimately, the reader must decide for themselves where the most desirable balance lies.
A single, objective performance metric can nonetheless be helpful in informing a comparative evaluation of diagnostic systems, and several such metrics exist for binary classifiers. AUROC is a commonly used approach, but one cannot plot the ROC curve nor calculate AUROC for human classifiers or a fixedthreshold system such as the current STE criteria. 24 Other investigators have calculated the ROC for the mean predictions a panel of human classifiers, 25 but with n=3 experts it was felt that this would produce unreliable and potentially misleading results. Net reclassification indices (NRI) are also favoured for comparing diagnostic systems but cannot be applied to non-probability-based classifiers. 26 Sensitivity and specificity are useful points of reference but make a poor basis for absolute comparison: this is highlighted by the fact that the STE classifier from our study produced a sensitivity approximately equal to random chance on the overall test set (which few would consider desirable in a diagnostic test for a life-threatening condition), yet the very high specificity resulted in McNemar's test showing no statistically significant difference between it and any other classifier. We therefore identified the F1 score (see methods section for full equation) as a widely accepted comparative metric in this context. [27] [28] [29] On this basis, the DL model would be the classifier of choice for early detection of ACTCO, having outperformed all classifiers evaluated in this and other cited studies by a clear margin.
In drawing this conclusion, however, it is important to note that ACTCO is not synonymous with AMI. Patients with well induced collateral systems can completely occlude an artery without any demonstrable myocardial ischaemia. 30 One may also expect few adverse consequences following the occlusion of an artery whose dependent myocardium has been rendered non-viable by an old infarct. The STAFF III dataset does not contain data regarding a history of AMI among the study subjects, nor any description of collateral circulation in the area of the balloon inflation, nor biomarker results (which would, in any case, have been difficult to interpret following instrumentation of the coronaries). 31 The fact that the DL model is able to discriminate effectively between the two groups of ECGs strongly implies the presence of electrical sequelae of myocardial ischaemia within the positive samples, but it must be acknowledged as a limitation of this study that the extent of myocardial ischaemia cannot be evaluated. In clinical practice, quantification of the ischaemia burden and previous myocardial scarring has important implications for predicting treatment response. 32 Nonetheless, the proposed explanation for the DL model's superior performance regarding ACTCO detection, particularly compared with experienced cardiologists, is that it is able to discern patterns within the data that are associated with the early electrical effects of ischaemic myocardium but are too subtle for human detection. This has important implications: the ability to detect hyperacute ACTCO with greater sensitivity than current STE criteria and greater specificity than expert cardiologists could substantially streamline existing clinical pathways and allow us to detect patients currently being missed for PPCI. Furthermore, we are entering an era of wearable medical devices, which already include continuous, single-lead ECG monitoring and are likely to extend to multiple leads in the near future. [33] [34] [35] [36] The capacity for hyper-acute, automated detection of ischaemic changes will become a pressing issue when this happens. The real significance of these results, however, lies in the first demonstration (to the best of our knowledge) of "super human" ACTCO detection by a DL model, which opens the door on a large number of exciting future applications of this technology.
In order to understand why we would propose this as a significant event, one must be aware of two key advantages that DL classifiers have over their "rulebased" predecessors. The first advantage lies in a DL model's facility for ongoing adaptation to new data. (For further information or clarification regarding this and other fundamental DL concepts asserted during the following discussion, we direct readers to Goodfellow et al, 2016 . 37 ) Our model was trained on a small dataset, consequently its performance may not immediately generalise well to the wider population, where it will encounter confounding features such as rhythm abnormalities or intraventricular conduction delays. However, DL systems have the potential to selfremediate "online". This is to say that, as long as the model is in receipt of an ongoing stream of ground truth data (i.e. for a proportion of ECGs that it classifies, it is subsequently told whether or not the patient had ACTCO at angiography), it is possible to have it adjust its own algorithms to better handle confounding features such as those described above, and to hone in on the patterns that are truly specific to the target patient group. Thus, where automated ECG analysers have historically achieved their best performance at the point of inception and on the dataset with which they were trained, a deep-learning-based analyser may become more robust in proportion to the amount of real-world data it encounters.
In the authors' opinion, however, there is another advantage of DL models over conventional systems that makes them particularly exciting from a clinical standpoint: their potential to uncover new information within existing data. In the context of ECG analysers, traditional systems have only been able to look where clinicians and engineers point them, so that AMI detectors will look for Q waves, ST shift, T wave changes and so on. DL models work on a very different premise: they are simply fed a stream of input data (in this case, ECG signals) and corresponding output labels (ACTCO vs no ACTCO) and expected to learn for themselves the patterns that map the former to the latter. This framework has its downsides, most notably that it can be very difficult to visualise the processes by which such models reach their diagnoses and thus to identify potential weaknesses and bias within the algorithms. But the substantial upside is that these models are free to find completely new frameworks for processing existing data. In this way, DL applications are already revealing hereto undiscovered patterns within familiar clinical media, whether that be subtle radio-isotope diffusion patterns within computerised tomographypositron emission tomography (CT-PET) of the brain signifying incipient Alzheimer disease, or some new way of looking at an ECG that allows for the hyperacute identification of ACTCO. 16 Following the results of this study, we believe there is a clear rationale for further research into the ability of DL models to detect ACTCO, and ultimately a prospective clinical trial whereby the decision to take patients for PPCI is informed, at least in part, by such a model. We also hope that this technology may prompt a re-think of the STEMI vs. NSTEMI classification system, in acknowledgement of the fact that ST segments do not contain the whole story regarding ACTCO. Furthermore, the demonstration of hitherto underutilised information within 12 lead ECG signals regarding the presence of myocardial ischaemia warrants a revisiting of existing forms of cardiac investigations. In particular, it may be that deeplearning-based analysis of ECGs recorded during stress offers a new lease of life to the traditional treadmill test or enhances the diagnostic capabilities of other testing modalities such as dobutamine stress echocardiography. DL technology is still in its infancy but it is the authors' belief that the "AI revolution" has enormous potential to change existing medical practice for the better, particularly in a specialty as rich in complex data as cardiology. As a concluding remark, however, we would sound a note of caution regarding its use in the healthcare domain. "Machine intelligence" is not a new concept, but the leading-edge systems of the last decade bear little resemblance to their rule-based predecessors. Hidden algorithm bias and "black-box" decisionmaking are ready examples of features endemic to modern systems that are still poorly-understood and whose implications could be catastrophic in a clinical context. (See the two press articles in the bibliography for examples of these effects in other domains. 38, 39 ) We would strongly advocate that the introduction of deeplearning-based tools to real-world clinical practice be undertaken judiciously, and particularly that every effort is made to raise the level of understanding of this technology among clinicians.
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